Entrada Therapeutics Inc (TRDA) — Defensive Interval Ratio
Entrada Therapeutics Inc (TRDA) has a Defensive Interval Ratio of 3598 days as of September 2025. Defensive assets of $236.75 Million (cash $-, short-term investments $233.55 Million, receivables $3.20 Million) cover 3598 days of daily cash needs of $65.81K/day. Check Entrada Therapeutics Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Entrada Therapeutics Inc Defensive Interval Ratio (2021–2024)
This chart shows how Entrada Therapeutics Inc's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 3598 days, meaning defensive assets of $236.75 Million can fund 3598 days of operations without new revenue. Also explore how fast is Entrada Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Entrada Therapeutics Inc (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for Entrada Therapeutics Inc from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Entrada Therapeutics Inc market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 2981 days | $322.47 Million | $108.17K/day | $- | $318.79 Million | ▲ +2314 days |
| 2023 | 667 days | $290.25 Million | $435.06K/day | $- | $284.37 Million | ▼ -1718 days |
| 2022 | 2385 days | $143.56 Million | $60.20K/day | $- | $143.56 Million | ▲ +2337 days |
| 2021 | 47 days | $872.00K | $18.41K/day | $- | $0.00 | — |